JAGUAR HEALTH, INC.

Profile

Company Names

JAGUAR HEALTH, INC.
JAGUAR ANIMAL HEALTH, INC.

Addresses

200 PINE ST., STE 400, SAN FRANCISCO, CA 94104

200 PINE STREET SUITE 400, SAN FRANCISCO, CA 94104

201 MISSION STREET, SUITE 2375, SAN FRANCISCO, CA 94105

185 BERRY STREET, SUITE 1300, SAN FRANCISCO, CA 94107

Phone Numbers

415-371-8300
415-896-5081

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BUSINESS SERVICES, OTHER HEALTH CARE

Year Incorporated:

2013

State Incorporated:

DELAWARE

Total Amount Raised:

$146,422,159.00

Number of Funding Rounds:

39
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
39
2026-06-09 
$2,000,000.00 
$2,000,000.00 
$0.00 
Equity 
38
2025-11-12 
$10,810,000.00 
$10,810,000.00 
$0.00 
Debt 
37
2025-09-28 
$1,000,000.00 
$1,000,000.00 
$0.00 
Equity 
36
2025-09-10 
$2,377,000.00 
$2,377,000.00 
$0.00 
Equity 
35
2025-05-20 
$1,500,003.00 
$1,500,003.00 
$0.00 
 
34
2023-09-01 
$60,000.00 
$60,000.00 
$0.00 
Equity 
33
2023-05-08 
$1,857,453.00 
$1,857,453.00 
$0.00 
Equity 
32
2022-09-23 
$7,140.00 
$7,140.00 
$0.00 
Equity 
31
2022-08-24 
$12,000,000.00 
$12,000,000.00 
$0.00 
Debt 
30
2022-06-28 
$300,000.00 
$10,000,000.00 
$9,700,000.00 
Equity 
29
2022-03-07 
$7,572.00 
$7,572.00 
$0.00 
Equity 
28
2021-09-13 
$776,197.00 
$776,197.00 
$0.00 
Equity 
27
2021-09-01 
$50,820.00 
$50,820.00 
$0.00 
Equity 
26
2021-04-05 
$39,800.00 
$39,800.00 
$0.00 
Equity 
25
2021-03-08 
$10,000,000.00 
$10,000,000.00 
$0.00 
Debt 
24
2021-01-19 
$6,220,812.00 
$6,220,812.00 
$0.00 
Debt 
23
2020-12-22 
$12,000,000.00 
$12,000,000.00 
$0.00 
Debt 
22
2020-09-01 
$1,087,500.00 
$1,087,500.00 
$0.00 
Equity 
21
2020-05-21 
$4,447,779.00 
$4,447,779.00 
$0.00 
 
20
2020-03-24 
$2,030,000.00 
$2,030,000.00 
$0.00 
Equity 
19
2020-03-23 
$720,000.00 
$720,000.00 
$0.00 
Equity 
18
2019-12-24 
$1,500,000.00 
$1,500,000.00 
$0.00 
Equity 
17
2019-03-18 
$800,000.00 
$12,100,000.00 
$11,300,000.00 
Debt 
16
2018-09-11 
$774,844.00 
$774,844.00 
$0.00 
Debt 
15
2018-08-28 
$569,998.00 
$569,998.00 
$0.00 
 
14
2018-03-26 
$2,240,909.00 
$2,240,909.00 
$0.00 
Debt 
13
2018-03-23 
$9,199,001.00 
$9,199,001.00 
$0.00 
Equity 
12
2018-03-21 
$1,090,340.00 
$1,090,340.00 
$0.00 
Debt 
11
2017-12-27 
$801,100.00 
$1,970,000.00 
$1,168,900.00 
Equity 
10
2017-12-08 
$1,587,500.00 
$1,587,500.00 
$0.00 
Debt 
9
2017-07-31 
$44,796,553.00 
$44,796,553.00 
$0.00 
Equity 
8
2017-06-29 
$2,155,000.00 
$2,155,000.00 
$0.00 
Debt 
7
2015-03-20 
$1,000,000.00 
$1,500,000.00 
$500,000.00 
Debt 
6
2014-12-23 
$900,000.00 
$4,000,000.00 
$3,100,000.00 
Debt 
5
2014-12-03 
$1,000,000.00 
$1,000,000.00 
$0.00 
Debt 
4
2014-08-26 
$1,112,500.00 
$1,112,500.00 
$0.00 
Debt 
3
2014-06-02 
$300,000.00 
$300,000.00 
$0.00 
Debt 
2
2014-02-05 
$6,777,338.00 
$6,780,900.00 
$3,562.00 
Equity 
1
2013-07-08 
$525,000.00 
$1,300,000.00 
$775,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ARI 
 
AZHIR 
DIRECTOR
NEURALTUS PHARMACEUTICALS, INC.   |  JAGUAR HEALTH, INC.   |  AQUYRE BIOSCIENCES INC
JAMES 
 
BOCHNOWSKI 
DIRECTOR
PHOTOTHERA INC   |  PIXELOPTICS INC   |  ELENZA, INC   |  JAGUAR ANIMAL HEALTH, INC.   |  SYNERGEYES INC   |  NIVEUS MEDICAL, INC.   |  JAGUAR HEALTH, INC.
JAMES 
J. 
BOCHNOWSKI 
DIRECTOR
PIXELOPTICS INC   |  ELENZA, INC   |  SEQUENT MEDICAL, INC.   |  JAGUAR HEALTH, INC.
JOSEPH 
 
BOCHNOWSKI 
DIRECTOR
JAGUAR ANIMAL HEALTH, INC.
PRAVIN 
 
CHATURVEDI 
EXECUTIVE OFFICER
NAPO PHARMACEUTICALS INC   |  PIVOT PHARMACEUTICALS INC.   |  JAGUAR HEALTH, INC.
LISA 
 
CONTE 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
NAPO PHARMACEUTICALS INC   |  JAGUAR ANIMAL HEALTH, INC.   |  JAGUAR HEALTH, INC.
GREG 
 
DIVAS 
DIRECTOR
JAGUAR HEALTH, INC.
GREG 
 
DIVIS 
DIRECTOR
JAGUAR HEALTH, INC.
GREG 
J. 
DIVIS 
DIRECTOR
JAGUAR HEALTH, INC.
ANULA 
 
JAYASURIYA 
DIRECTOR
NVISION MEDICAL CORP   |  SOLAREA BIO, INC.   |  AARVIK THERAPEUTICS, INC.   |  JAGUAR HEALTH, INC.
JEFFERY 
 
JOHNSON 
DIRECTOR
JUMPEDAL CORP   |  JAGUAR HEALTH, INC.   |  VR ARGENTINA RECOVERY ONSHORE FUND II, L.P.
JEFFREY 
 
JOHNSON 
DIRECTOR
ECOENVELOPES, LLC   |  MBH ENTERPRISES LLC   |  AL-MS GROUP, LLC   |  VR GLOBAL ONSHORE FUND, L.P.   |  BFC-DED, LLC   |  VR GLOBAL OFFSHORE FUND LTD.   |  JAGUAR HEALTH, INC.   |  VR ARGENTINA RECOVERY OFFSHORE FUND II LTD.   |  CWRP FRESENIUS INVESTORS, LLC   |  BRE III SPE X LLC   |  PIMCO MORTGAGE INVESTMENT TRUST, INC.   |  CWRP SR CANCER CENTER INVESTORS, LLC   |  MPC CONSOLIDATION, LLC   |  CARROLL COUNTY BANCSHARES, INC. / IA   |  BRAVELANE ALMADEN HOLDINGS LLC   |  MOTION AT DADELAND HOLDINGS, LLC   |  NASHVILLE HA HOLDCO LLC   |  HOTEL DC HOLDCO LLC   |  VR ARGENTINA RECOVERY ONSHORE FUND II, L.P.   |  BLACKFORD CAPITAL TARGETED OPPORTUNITY FUND I FEEDER, L.P.   |  BLACKFORD CAPITAL TARGETED OPPORTUNITY FUND I, L.P.   |  BLACKFORD CAPITAL TARGETED OPPORTUNITY FUND I-A, L.P.
JEFFREY 
B. 
JOHNSON 
DIRECTOR
JAGUAR HEALTH, INC.
JEFFREY 
C 
JOHNSON 
DIRECTOR
JAGUAR HEALTH, INC.
JEFFREY 
C. 
JOHNSON 
DIRECTOR
JAGUAR HEALTH, INC.
JOHN 
 
KALLASSY 
EXECUTIVE OFFICER
JAGUAR ANIMAL HEALTH, INC.   |  IB DIRECT, LLC   |  BACTANA CORP.   |  TORIGEN PHARMACEUTICALS, INC.   |  STATERA BIOPHARMA, INC.
JOHN 
A. 
KALLASSY 
EXECUTIVE OFFICER
JAGUAR ANIMAL HEALTH, INC.
FOLKERT 
 
KAMPHUIS 
DIRECTOR
JAGUAR HEALTH, INC.
STEVEN 
 
KING 
EXECUTIVE OFFICER
NAPO PHARMACEUTICALS INC   |  INNOTAS   |  JAGUAR ANIMAL HEALTH, INC.   |  JAGUAR HEALTH, INC.   |  VIRALCLEAR PHARMACEUTICALS, INC.
STEVEN 
R. 
KING 
EXECUTIVE OFFICER
JAGUAR HEALTH, INC.
CAROL 
 
LIZAK 
EXECUTIVE OFFICER
JAGUAR HEALTH, INC.
MURRAY 
 
MACNAUGHTAN 
DIRECTOR
JAGUAR HEALTH, INC.
MURRAY 
DAVID 
MACNAUGHTAN 
DIRECTOR
JAGUAR HEALTH, INC.
SERGE 
 
MARTINOD 
EXECUTIVE OFFICER
TNG PHARMACEUTICALS, INC.   |  JAGUAR ANIMAL HEALTH, INC.
JOHN 
 
MICEK III 
DIRECTOR
JAGUAR HEALTH, INC.
JOHN 
 
MICEK, III 
DIRECTOR
JAGUAR HEALTH, INC.
JIAHAO 
 
QUI 
DIRECTOR
JAGUAR HEALTH, INC.
JIAHAO 
JIAHAO 
QUI 
DIRECTOR
JAGUAR HEALTH, INC.
JOE 
 
QUI 
DIRECTOR
JAGUAR ANIMAL HEALTH, INC.   |  JAGUAR HEALTH, INC.
JONATHAN 
 
SIEGEL 
DIRECTOR
K-V PHARMACEUTICAL CO   |  DELIVERED.IO, INC.   |  LABCONNECT HOLDINGS, INC.   |  JAGUAR HEALTH, INC.   |  JUNO RESIDENTIAL, INC.   |  XENON INVESTMENT FUND 5, L.P.
JONATHAN 
B 
SIEGEL 
DIRECTOR
JAGUAR HEALTH, INC.
JONATHAN 
B. 
SIEGEL 
DIRECTOR
JAGUAR HEALTH, INC.
CHARLES 
 
THOMPSON 
EXECUTIVE OFFICER
COBALT FUND LP   |  NAPO PHARMACEUTICALS INC   |  DIGITAL MANAGEMENT, INC.   |  BLACK BEAR FOREST INC   |  JAGUAR ANIMAL HEALTH, INC.   |  EZ STORE, LLC   |  EVERGREEN AT RIVER OAKS INVESTORS, LP
CHARLES 
 
THOMSPN 
EXECUTIVE OFFICER
JAGUAR ANIMAL HEALTH, INC.
JONATHAN 
 
WOLIN 
EXECUTIVE OFFICER
JAGUAR HEALTH, INC.
JONATHAN 
 
WOLING 
EXECUTIVE OFFICER
JAGUAR HEALTH, INC.
KAREN 
 
WRIGHT 
EXECUTIVE OFFICER
JAGUAR HEALTH, INC.
KAREN 
S. 
WRIGHT 
EXECUTIVE OFFICER
JAGUAR HEALTH, INC.
ZHI 
 
YANG 
DIRECTOR
XUNNA INFORMATION TECHNOLOGY INC.   |  BVCF III, L.P.   |  EXPLORAMED NC6, INC.   |  JAGUAR ANIMAL HEALTH, INC.   |  JAGUAR HEALTH, INC.   |  BVCF IV, L.P.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-07-01
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2026-06-09 
2026-07-01
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2026-06-09 
2025-11-24
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2025-11-12 
2025-10-10
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-09-28 
2025-09-23
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-09-10 
2025-05-28
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2025-05-20 
2023-11-30
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-09-01 
2023-05-11
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-05-08 
2023-05-11
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-05-08 
2022-09-23
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-09-23 
2022-09-02
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2022-08-24 
2022-07-08
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-06-28 
2022-04-26
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-09-01 
2022-04-25
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-03-07 
2022-04-25
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-04-05 
2021-09-24
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-09-13 
2021-03-26
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2021-03-08 
2021-02-04
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2021-01-19 
2021-02-04
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2020-12-22 
2020-09-17
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-09-01 
2020-06-05
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2020-05-21 
2020-04-08
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-03-23 
2020-04-07
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-03-24 
2020-01-06
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-12-24 
2019-04-03
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2019-03-18 
2018-09-27
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2018-09-11 
2018-09-24
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2018-08-28 
2018-04-02
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-03-23 
2018-04-02
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-03-23 
2018-04-02
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2018-03-21 
2018-04-02
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2018-03-26 
2018-03-30
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2017-12-08 
2018-03-30
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2017-06-29 
2018-01-11
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-12-27 
2017-08-30
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-07-31 
2015-04-02
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2015-03-20 
2015-03-09
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2014-12-23 
2015-03-06
D
Link
BUSINESS SERVICES 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2014-12-03 
2014-09-12
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2014-08-26 
2014-06-16
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2014-06-02 
2014-06-04
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2013-07-08 
2014-05-07
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2014-02-05 
2014-02-10
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2014-02-05 
2013-09-05
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2013-07-08 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
000000375